Study of MEDI0382 in combination with Dapagliflozin and metformin in overweight/Obese Participants with Type 2 Diabetes

Trial Identifier: D5670C00007
Sponsor: MedImmune, LLC
NCTID:: NCT03444584
Start Date: May 2018
Primary Completion Date: December 2018
Study Completion Date: December 2018
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Hungarian Translation
German Translation

Trial Locations

Country Location
Germany Magdeburg, Germany, 39120
Germany Mannheim, Germany, 68167
Germany München, Germany, 81241
Hungary Balatonfüred, Hungary, 8230
Hungary Miskolc, Hungary, 3529
Hungary Szeged, Hungary, 6720
United Kingdom Manchester, United Kingdom, M13 9NQ
United Kingdom Rotherham, United Kingdom, S65 1DA